linagliptin

noun

lin·​a·​glip·​tin ˌlin-ə-ˈglip-tən 

: a hypoglycemic drug C₂₅H₂₈N₈O₂ taken orally in the treatment of type 2 diabetes

Note: Linagliptin acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Tradjenta and when used in combination with metformin, under the trademark Jentadueto.